Radiotherapy is used to treat gross and microscopic disease in low grade glioma. This chapter will address controversies of dose, timing, techniques, recent advances in the field and the benefit of systemic therapy. With the advent of molecular classification, current understanding of the role and benefit of radiotherapy in this diverse population is rapidly changing.
